JG
CVS icon

Jefferies Group’s CVS Health CVS Stock Holding History

Jefferies Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,000
Closed -$8.49M – 1697
2021
Q3 		$8.49M Buy
+100,000
New +$8.38M 0.06% 305
2021
Q1 		– Sell
-215,900
Closed -$14.7M – 1694
2020
Q4 		$14.7M Buy
215,900
+42,500
+25% +$2.76M 0.12% 144
2020
Q3 		$10.1M Buy
173,400
+21,400
+14% +$1.33M 0.11% 147
2020
Q2 		$9.88K Sell
152,000
-79,100
-34% -$4.98M 0.12% 139
2020
Q1 		$13.7M Sell
231,100
-58,100
-20% -$3.88M 0.15% 104
2019
Q4 		$21.5M Buy
289,200
+185,600
+179% +$13M 0.17% 100
2019
Q3 		$6.53M Buy
103,600
+37,100
+56% +$2.2M 0.05% 388
2019
Q2 		$3.62M Sell
66,500
-155,600
-70% -$8.38M 0.03% 626
2019
Q1 		$12M Buy
222,100
+58,300
+36% +$3.6M 0.1% 169
2018
Q4 		$10.7M Sell
163,800
-369,900
-69% -$27.6M 0.09% 183
2018
Q3 		$42M Buy
533,700
+81,700
+18% +$5.84M 0.27% 45
2018
Q2 		$29.1M Buy
452,000
+244,700
+118% +$16.1M 0.16% 80
2018
Q1 		$12.9M Buy
207,300
+153,700
+287% +$11M 0.07% 190
2017
Q4 		$3.89M Sell
53,600
-53,500
-50% -$3.89M 0.02% 661
2017
Q3 		$8.71M Buy
107,100
+99,200
+1,256% +$7.85M 0.06% 318
2017
Q2 		$636K Sell
7,900
-83,600
-91% -$6.6M ﹤0.01% 1502
2017
Q1 		$7.18M Sell
91,500
-65,600
-42% -$5.24M 0.05% 362
2016
Q4 		$12.4M Buy
157,100
+104,000
+196% +$8.42M 0.07% 277
2016
Q3 		$4.72M Sell
53,100
-2,500
-4% -$236K 0.02% 555
2016
Q2 		$5.32M Sell
55,600
-3,800
-6% -$379K 0.02% 478
2016
Q1 		$6.16M Sell
59,400
-23,000
-28% -$2.24M 0.04% 417
2015
Q4 		$8.06M Buy
82,400
+63,600
+338% +$6.23M 0.05% 324
2015
Q3 		$1.81M Sell
18,800
-7,500
-29% -$788K 0.01% 934
2015
Q2 		$2.76M Buy
+26,300
New +$2.69M 0.01% 761
2014
Q2 		– Sell
-32,800
Closed -$2.46M – 2122
2014
Q1 		$2.46M Buy
+32,800
New +$2.32M 0.02% 541

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's CVS Position: Q3 2022 in Review

Jefferies Group reduced its CVS Health (CVS) stake by 58% in Q3 2022, selling an estimated $421K and leaving 3,019 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Jefferies Group first reported a position in CVS in Q2 2013 and has held it in 36 quarters since. The position peaked at $17.8M in Q3 2016. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Jefferies Group held 3,019 shares of CVS Health worth $288K as of Q3 2022.
  • Jefferies Group sold 4,250 CVS Health shares in Q3 2022, an estimated $421K.
  • CVS Health made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1245 holding.
  • Jefferies Group first reported a position in CVS Health in Q2 2013 and has held it in 36 quarters since.
  • Jefferies Group's CVS Health position peaked at $17.8M in Q3 2016.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.